Science directors: Jean-Christophe Marine & Diether Lambrechts

Our research is focused on the interaction between cancer cells and the tumor microenvironment at an (epi)genetic, metabolic and phenotypic level. This places CCB in a unique position to develop novel insights and (combination) therapies considering the complexity and heterogeneous nature of the tumor ecosystem and targeting the cancer cells, TME, and/or interplay between these two components. Part of our mission is to identify more accurate biomarkers and methodologies that will revolutionize pathology. By going beyond the canonical bench-to-beside model and developing a bed-to-bench-and-back approach, we put the patients at the core of our integrative efforts.